ResMed Inc. (BMV:RMD)

DFS Statistics

Total Valuation

ResMed has a market cap or net worth of MXN 777.37 billion. The enterprise value is 770.70 billion.

Market Cap	777.37B
Enterprise Value	770.70B

Important Dates

The last earnings date was Thursday, July 31, 2025.

Earnings Date	Jul 31, 2025
Ex-Dividend Date	May 8, 2025

Share Statistics

Current Share Class	146.39M
Shares Outstanding	n/a
Shares Change (YoY)	-0.14%
Shares Change (QoQ)	-0.12%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	145.49M

Valuation Ratios

The trailing PE ratio is 29.43 and the forward PE ratio is 25.98.

PE Ratio	29.43
Forward PE	25.98
PS Ratio	8.01
PB Ratio	6.91
P/TBV Ratio	16.78
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.69, with an EV/FCF ratio of 24.59.

EV / Earnings	29.18
EV / Sales	8.02
EV / EBITDA	21.69
EV / EBIT	24.41
EV / FCF	24.59

Financial Position

The company has a current ratio of 3.44, with a Debt / Equity ratio of 0.14.

Current Ratio	3.44
Quick Ratio	2.16
Debt / Equity	0.14
Debt / EBITDA	0.45
Debt / FCF	0.51
Interest Coverage	2,884.43

Financial Efficiency

Return on equity (ROE) is 25.86% and return on invested capital (ROIC) is 16.80%.

Return on Equity (ROE)	25.86%
Return on Assets (ROA)	14.02%
Return on Invested Capital (ROIC)	16.80%
Return on Capital Employed (ROCE)	23.58%
Revenue Per Employee	9.16M
Profits Per Employee	2.49M
Employee Count	9,980
Asset Turnover	0.68
Inventory Turnover	2.09

Taxes

In the past 12 months, ResMed has paid 5.22 billion in taxes.

Income Tax	5.22B
Effective Tax Rate	16.50%

Stock Price Statistics

The stock price has increased by +35.47% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+35.47%
50-Day Moving Average	4,823.46
200-Day Moving Average	4,809.09
Relative Strength Index (RSI)	97.62
Average Volume (20 Days)	33

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	10.00

Income Statement

In the last 12 months, ResMed had revenue of MXN 97.05 billion and earned 26.42 billion in profits. Earnings per share was 179.34.

Revenue	97.05B
Gross Profit	58.22B
Operating Income	31.82B
Pretax Income	31.64B
Net Income	26.42B
EBITDA	35.08B
EBIT	31.82B
Earnings Per Share (EPS)	179.34

Balance Sheet

The company has 22.81 billion in cash and 16.06 billion in debt, giving a net cash position of 6.74 billion.

Cash & Cash Equivalents	22.81B
Total Debt	16.06B
Net Cash	6.74B
Net Cash Per Share	n/a
Equity (Book Value)	112.54B
Book Value Per Share	768.81
Working Capital	46.89B

Cash Flow

In the last 12 months, operating cash flow was 33.03 billion and capital expenditures -1.69 billion, giving a free cash flow of 31.34 billion.

Operating Cash Flow	33.03B
Capital Expenditures	-1.69B
Free Cash Flow	31.34B
FCF Per Share	n/a

Margins

Gross margin is 59.99%, with operating and profit margins of 32.79% and 27.22%.

Gross Margin	59.99%
Operating Margin	32.79%
Pretax Margin	32.60%
Profit Margin	27.22%
EBITDA Margin	36.15%
EBIT Margin	32.79%
FCF Margin	32.29%

Dividends & Yields

This stock pays an annual dividend of 41.98, which amounts to a dividend yield of 0.81%.

Dividend Per Share	41.98
Dividend Yield	0.81%
Dividend Growth (YoY)	27.54%
Years of Dividend Growth	1
Payout Ratio	22.19%
Buyback Yield	0.14%
Shareholder Yield	0.95%
Earnings Yield	3.40%
FCF Yield	4.03%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ResMed has an Altman Z-Score of 12.06 and a Piotroski F-Score of 7.

Altman Z-Score	12.06
Piotroski F-Score	7